ArticleNAR genomics and bioinformatics2026
Systematic evaluation of the heterogeneity of topologically associating domain boundaries in a large genomic context in humans.
Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating heterogeneity into topologically associating domain boundary prediction in large genomic context in human.NAR genomics and bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Topologically associating domains (TADs) are generally considered as a homogeneous basic units of genome folding, which is critical for transcriptional regulation. However, recent studies indicate that both the TAD domain structures and the boundaries between them are not as homogeneous as originally recognized. Here, we address the heterogeneity of the TAD boundaries in the human genome at a large scale, which varies between active and inactive chromatin and across cell lines and tissues. To address this, based on the well-annotated TAD boundaries extracted from multiple cell lines and tissues, we examine their nucleotide content, resulting in two main clusters, one GC-rich and one AT-rich, which are mainly distributed in active and inactive chromatin, respectively. Also, they contain different types of repetitive sequences and have different epigenetic patterns, with more CTCF binding motifs in the GC-rich cluster. Hence, our observations of the TAD boundary content provide novel insights into TAD genomic architecture. In addition, we find that cell- or tissue-specific boundaries are less evolutionarily conserved than other boundaries. We highlight the importance of TAD boundary diversity in different functional contexts and discuss the importance of the different types of repetitive sequences and epigenetic patterns in the two main types of boundaries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.